Lymphatic mapping and sentinel lymph node biopsy on cutaneous malignant melanoma;Mapeo linfático y biopsia del ganglio centinela en el melanoma cutáneo

Actas Dermo-Sifiliograficas

Volumn 92, Issue 7-8, 2001, Pages 319-333

  Ochaita, Pablo Lázard ^a   Copano, Ángel Bittini ^a   Marco, Celso Bueno ^a   Cortés, José Luis Escat ^a   Echevarría, Manuel Lecona ^a   Santos, Susana Pérez ^a  

^a NONE

Author keywords

Gamma probe; Isotopic lymphoscintagraphy; Lymphatic metastasis; Melanoma; Melanoma diagnosis; Sentinel node

Indexed keywords

EID: 0038451130     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(01)79149-1     Document Type: Article

References (98)

1. Espinosa Arranz J, Bravo Fernández P, Sánchez Hernández JJ González Barón M. Epidemiología y factores de riesgo. En: González Barón M, Ordóñez Gallego A, eds. Melanoma. Barcelona: Masson; 1998. p. 1-27.
2. Jelfs PL, Coates M, Giles G. Cancer in Australia 1989-1990 (with projections to 1995). En: Cancer series n. ° 5. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries, Canberra; 1996.
3. Serrano S. Incidencia de melanoma en España. Registro Nacional de Melanomas. En: Libro de Resúmenes XXVII Congreso Nacional de Dermatología y Venereología. Santander; 1998. p. 32-3.
4. Testori A. Letter to the editor. Melanoma Res 1999;9:619-20.
5. Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: results of a metaanalysis. Melanoma Res 2000;10:81-92.
6. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991; 214:491-501.
7. García-Sancho Martín L, García-Sancho Téllez L. Cirugía del melanoma cutáneo. En: González Barón M, Ordóñez Gallego A. Melanoma. Barcelona: Masson; 1998. p. 149-71.
8. a ed. San Luis: Quality Medical Publishing; 1998. p. 209-25.
9. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N EnglJ Med 1977;297:627-30.
10. Veronesi U, AdamusJ, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
11. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697.
12. Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-66.
13. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 1998;351:793-6.
14. McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964;56:512-8.
15. Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg 1977;186:201-9.
16. Cohen MH, Ketcham AS, Felix EL, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;186:635-42.
17. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma, III: prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-88.
18. Gallery C, Cochran AJ, Roe DJ. Factors prognostics for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982; 196:69-75.
19. Roses DF, Provet JA, Harris MN, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg 1985;201:103-7.
20. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
21. Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 1997;66:267-9.
22. Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or «watch and wait». Surg Oncol Clin North Am 1992;1:247.
23. Wong JH, Cagle LA, que Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991;214:637-41.
24. Alex JC, Krad DN. Gamma-probe-guided localization of lymph nodes. Surg Oncol 1993;2:137-43.
25. Ross MI, Reinigen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993;9:219-23.
26. Reinigen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, et al. The orderly progression of melanoma nodal metaslases. Ann Surg 1994;220:759-67.
27. Thompson JF, McCarlhy WH, Bosch CM, O'Brien CJ, Quinn MJ, Paramaesvaran S, Crotty K, McCarthy SW, Uren RF, Howman-Giles R. Sentinel lymph node slatus as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
28. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130: 654-8.
29. Blaheta HJ, Schittek B, Breuninger H, Sotlar K, Ellwanger U, Thelen MH, Maczey E, Rassner G, Bueltmann B, Garbe C, Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-8.
30. Hatta N, Fujimoto A, Takehara K, Takata M. Mapping of occult melanoma micrometastases in the inguinal lymph node basin by immunohistochemistry and RT-PCR. Melanoma Res 1999;9:401-6.
31. Lukowsky A, Bellmann B, Ringk A, Winter H, Audring H, Fenske S, Sterry W. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction. J Invest Dermatol 1999; 113:554-9.
32. Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reinigen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999;6:144-9.
33. Lenisa L, Santinami M, Belli F, Clemente C, Mascheroni L, Patuzzo R, Gallino G, Bergonzi M, Rao S, Polverelli M, Morelli R, Landi G, Cascinelli N. Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients. J Exp Clin Cancer Res 1999;18:69-74.
34. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ, Balch CM, Reintgen DS, Ross MI. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-83.
35. Morgan K, Hughes LE. Staging of melanoma. Clin Radiol 1993;48:297-300.
36. Buzaid AC, Sandler AB, Mani S. Role of Computern tomography in the staging of malignant melanoma. J Clin Oncol 1993; 11:638-43.
37. Rinne D, Baum RP, Hor G. Primary staging and followup of high risk melanoma patients with whole body 18 F-fluorodeoxyglucose positron emmission tomography: results of a prospective study of 100 patients. Cancer 1998;82: 1664-71.
38. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453-63.
39. Testori A, Bartolomei M, Grana C, Mezzetti M, Chinol M, Mazzarol G, Lazzari I, Paganelli G, Geraghty JG, Andreoni B, Veronesi U. Sentinel node localization in primary melanoma: learning curve and results. Melanoma Res 1999; 9:587-93.
40. Bongers V, Borel Rinkes IH, Barneveld PC, Canninga-van Dijk MR, Van Rijk PP, Van Vloten WA. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European survey. Eur J Nucl Med 1999;26:84-90.
41. Ross MI. Lymphatic mapping and sentinel node biopsy for early stage melanoma: how we do it at the M. D. Anderson Cancer Center. J Surg Oncol 1997;66:273-6.
42. Taylor A Jr, Murray D, Herda S, Vansant J, Alazraki N. Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. Clin Nucl Med 1996;21:755-8.
43. Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection-an overview. Eur J Nucl Med 1999;26(4 suppl) :S36-42.
44. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185-90.
45. Vidal-Sicart S, Piulachs J, Pons F, Castel T, Palou J, Herranz R. Sentinel lymph node detection with lymphoscintigraphy and intraoperative probe in malignant melanoma patients. Med Clin 1999;112:681-4.
46. Kelerrien PR, Essner R, Foshag LJ, Morton DL. Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma. J Am Coll Surg 1999; 189:247-52.
47. Karakousis CP, Grigoropoulos P. Sentinel node biopsy before and after wide excision of the primary melanoma. Ann Surg Oncol 1999;6:785-9.
48. a ed. San Luis: Quality Medical Publishing; 1998:227-44.
49. Leong SP, Achtem TA, Habib FA, Steinmetz I, Monta E, Allen RE, Kashani-Sabet M, Sagebiel R. Discordancy between clinical predictions vs lymphoscin tigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol 1999; 135:1472-6.
50. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435-40.
51. Kamath D, Rapaport D, DeConti R, Cruse CW, Wells K, Glass F, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reinigen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc 1997;84:182-7.
52. Uren RF, Howman-Giles RB, Thompson JF, Shaw HM, McCarthy WH. Lymphatic drainage from peri-umbilical skin to internal mammary nodes. Clin Nucl Med 1995;20: 254-5.
53. Uren RF, Howman-Giles R, Thompson JF, Quinn MJ. Direct lymphatic drainage from the skin of the forearm to a supraclavicular node. Clin Nucl Med 1996;21:387-9.
54. Uren RF, Howman-Giles R, Thompson JF, Quinn MJ, O'Brien C, Shaw HM, Bosch CM, McCarthy WH. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med 1996;37:964-6.
55. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH. Exclusive lymphatic drainage from a melanoma on the back to intraabdominal lymph nodes. Clin Nucl Med 1998; 23:71-3.
56. Vidal-Sicart S, Pons F, Piulachs J, Castel T Palou J, Herranz R. Mid-arm sentinel lymph nodes showing surprising drainage from a malignant melanoma in the forearm. Clin Nucl Med 1998;23:273-4.
57. Thompson JF, Uren RF, Shaw HM, McCarthy WH, Quinn MJ, O'Brien CJ, Howman-Giles RB. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999;189:195-204.
58. Glass LF, Albertini JJ, Frenske NA, Reingten DS. Lymphatic mapping and selective lymphadenectomy in patients with cutaneous melanoma. Current Opinion Dermatol 1996; 3:63-70.
59. Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J, et al. The role of selective lymphadenectomy in the manage-ment of patients with malignant melanoma. Dermatol Surg 1995;21:979-83.
60. Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reinigen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg 1996;22:715-20.
61. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reinigen DS. Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
62. Joseph E, MessinaJ, Glass FL, Cruse CW, Rapaport DP, Berman C, Reinigen DS. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am 1997;3:341-5.
63. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Alien RE Jr, Morita ET, el-Kadi M, Epstein HD, KashaniSabet M, Sagebiel RW. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-72.
64. Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH, Peterse JL, Valdes Olmos RA, Hoefnagel CA, Kroon BB. Localizing the sentinel node in cutaneous melanoma: gamma probe deiection versus blue dye. Ann Surg Oncol 1997;4:156-60.
65. Kapteijn BA, Nieweg OE, Muller SH, Liem IH, Hoefnagel CA, Rutgers EJ, Kroon BB. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 1997;38:362-6.
66. Gershenwald JE, Tseng CH, Thompson W, Mansfield PF, Lee JE, Bouvet M, Lee JJ, Ross MI. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998; 124:203-10.
67. Bostick P, Essner R, Glass E, Kelley M, Sarantou T, Foshag LJ, Qi K, Morton D. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999;134:43-9.
68. Gennari R, Bartolomei M, Testori A, Zurrida S, Stoldi HS, Audisio RA, GeraghtyJG, Paganelli G, Veronesi U. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery 2000;127:19-25.
69. Ollila DW, Foshag LJ, Essner R, Stern SL, Morton DL. Parotid region lymphatic mapping and sentinel lymphadeneciomy for cutaneous melanoma. Ann Surg Oncol 1999;6:150-4.
70. Wells KE, Stadelmann WK, Rapaport DP, Hamlin R, Cruse CW, Reinigen D. Parotid selective lymphadenectomy in malignant melanoma. Ann Plast Surg 1999;43:l-6.
71. Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, Vermey A, Plukker JT, Hoefnagel CA. Sentinel node biopsy for melanoma in the head and neck region. Head Neck 2000;22:27-33.
72. Carlson GW, Murray DR, Greenlee R, Alazraki N, Fry-Spray C, Poole R, Blais M, Hestley A, Vansant J. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg 2000; 126:433-7.
73. Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 2000;126:313-21.
74. Thompson JF, Niewind P, Uren RF, Bosch CM, Howman-Giles R, Vrouenraets BC. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in mel de anoma patients. Melanoma Res 1997;7:500-6.
75. Essner R, Bostick PJ, Glass EC, Foshag LJ, Haigh PI, Wang HJ, Morton DL. Standardized probe-directed sentinel node dissection in melanoma. Surgery 2000;127:26-31.
76. White DC, Schuler FR, Pruitt SK, Culhane DK, Seigier HF, Coleman RE, Tyler D. Timing of sentinel lymph node mapping after lymphoscintigraphy. Surgery 1999;126:156-61.
77. Yu LL, Flotte TJ, Tanabe KK, Gadd MA, Cosimi AB, Sober AJ, Mihm MC Jr, Duncan LM. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999; 86:617-27.
78. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23: 686-90.
79. Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med 2000;30:11-7.
80. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, Balch CM, Ross MI. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
81. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, Souba WW, Ott MJ, Wong LS, Sober AJ, Mihm MC, Haluska FG, Tanabe KK. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999;134:381-7.
82. Gibbs JF, Huang PP, Zhang PJ, Kraybill WG, Cheney R. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999;6:699-704.
83. Botella Estrada R, Sopena Barona J, Nogueira Vazquez E, Carpio Mañez D, Sanmartín Jiménez O, Sevila Llinares A, Guillén Barona C. Desarrollo de un test para la detección y cuantificación de células de melanoma en sangre periférica mediante el análisis del RNAm de la tirosinasa por RT-PCR y empleo de un secuenciador automático. Actas Dermosifiliog 1999;90:419-31.
84. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, De Weger RA, De Graaf PW, Tilanus MG, Van den Tweel JG. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759-64.
85. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, Essner R, Hoon DS. Prognostic significance of occult métastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.J Clin Oncol 1999; 17:3238-44,
86. Goydos JS, Ravikumar TS, Germino FJ, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998; 187:182-8.
87. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse GW, Berman G, Fenske NA, Lyman GH, Reintgen DS. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-5.
88. Bieligk SC, Ghossein R, Bhattacharya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999;6:232-40.
89. Blaheta HJ, Schittek B, Breuninger H, Sotlar K, Ellwanger U, Thelen MH, Maczey E, Rassner G, Bueltmann B, Garbe C. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-8.
90. Van der Velde-Zimmermann D, Scrapper ME, De Weger RA, Hennipman A, Borel Rinkes IH. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and costeffective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol 2000;7:51-4.
91. Bautista NC, Cohan S, Anders KH. Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and inmunohistochemical study with literature review. Am J Clin Pathol 1994; 102:102-8.
92. Carson KF, Wen DR, Li PX, Lana AM, Bailly C, Morton DL, Cochran AJ. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
93. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637-42.
94. Wagner JD, Schauwecker D, Davidson D, Coleman JJ. Prospective study of fluorodeoxyglucose Positron Emission Tomograpghy imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 1999; 17:1508-15.
95. Landi G, Polverelli M, Moscatelli G, Morelli R, Landi C, Fiscelli O, Erbazzi A. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases. J Eur Acad Dermatol 2000; 14:35-47.
96. Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, Cruse CW, Rapaport DP, Berman C, Fenske N, Reinigen DS. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 1998;5:119-25
97. Essner R, Conforti A, Kelley MC, Wanek L, Stern S, Glass E, Morton DL. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;6:442-9.
98. Morton DL, Chan AD. The concept of sentinel node localization: how it started. Semin Nucl Med 2000;30:4-10.